View the NewsRx Library

Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Google 2009 PageRank: #2 Among Top Health News and Media Publications

Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology

Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals

Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This site complies with the HONcode standard for trustworthy health information:
verify here.

Search Results for Biopharmaceuticals

Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20 Next >

Refine Search

Display Mode: Context | Summary

Monsanto to Purchase Chesterfield Village Research Center From Pfizer

2009 NOV 23 ... the transaction in the first half of 2010. Keywords: Bioengineering, Biopharmaceuticals, Biotechnology, Pfizer, Pharmaceutical Business, Pharmaceutical Company, ...

Subject: Bioengineering

Price: $3.00

Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million

2009 NOV 23 ... doubled its net sales to approximately US$25 million in 2008. Keywords: Biopharmaceuticals, Biotechnology, Clinical Trial Research, Drugs, H1N1 Virus, Immunization, Infectious ...

Subject: H1N1 Virus

Price: $3.00

Novartis to Acquire Majority Stake in Hard to Treat Diseases' HTDS.PK China Subsidiary H1N1 Vaccine Partner for US$125 Million

2009 NOV 23 ... Advertising, Asia, China, Finance, Financial, Investing, Investment, Marketing, Biopharmaceuticals, Biotechnology, Clinical Trial Research, Drugs, H1N1 Virus, Immunization, Infectious ...

Subject: Hard to Treat Diseases HTDS

Price: $3.00

Once-Daily INTUNIV guanfacine Extended Release Tablets Now Available in Pharmacies Nationwide

2009 NOV 28 ... Adrenergic alpha-Agonist, Antihypertensive, Attention Deficit Hyperactivity Disorder, Biopharmaceuticals, Clinical Research, Clinical Trial Research, Developmental Disabilities, Drugs, ...

Subject: Shire plc

Price: $3.00

Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide

2009 NOV 23 ... Adrenergic alpha-Agonist, Antihypertensive, Attention Deficit Hyperactivity Disorder, Biopharmaceuticals, Clinical Research, Clinical Trial Research, Developmental Disabilities, Drugs, FDA, ...

Subject: Pediatrics

Price: $3.00

OTCBB-WNDM Announces Activation of BioPharma Division to Solicit Technology and Development Partners

2009 NOV 23 ... Information please call Ronnie Ambrose at 954-357-0614. Keywords: Biopharmaceuticals, Biotechnology, Drugs, Embryonic Stem Cells, Pharmaceuticals, Stem Cell Research, ...

Subject: Biopharmaceuticals

Price: $3.00

PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument

2009 NOV 23 ... technology worldwide. The company's website is www.mortara.com. Keywords: Biopharmaceuticals, Cardio Device, Cardiology, Cardiovascular, Clinical Trial Research, Diagnostics, Drugs, ...

Subject: Biopharmaceuticals

Price: $3.00

Pharmaceutical Employer Market Strategies: Influencing the Influencers

2009 NOV 23 ... clients include 48 out of the top 50 pharmaceutical companies. Keywords: Biopharmaceuticals, Biotechnology Business, Biotechnology Company, Drugs, Genentech Inc., Novartis AG, ...

Subject: Pharmaceuticals

Price: $3.00

Pharmacyclics to Present at Merriman Curhan Ford's Investor Summit 2009

2009 NOV 23 ... website, please go to http://ir.pharmacyclics.com/events.cfm. Keywords: Biopharmaceuticals, Cancer, Clinical Trials, Drugs, Immune-mediated Disease, Oncology, Pharmaceutical ...

Subject: Pharmaceuticals

Price: $3.00

PIKAMAB to Customize Cancer Antibody Therapies

2009 NOV 23 ... Keywords: , Health, Biotechnology, Clinical Trials, Oncology, Pharmaceutical, Biopharmaceuticals, Biotechnology, Breast Cancer, Breast Carcinoma, Cetuximab, Chemotherapy, Clinical Trial ...

Subject: PIKAMAB

Price: $3.00

Shire Reports Findings From an Analysis Examining Emotional Lability in Children With ADHD Taking Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII

2009 NOV 23 ... in Las Vegas. Keywords: ADHD, Attention Deficit Hyperactivity Disorder, Biopharmaceuticals, Clinical Trial Research, Developmental Disabilities, Drugs, Lisdexamfetamine ...

Subject: Pediatrics

Price: $3.00

Studies from Can-Fite BioPharma yield new data on arthritis

2009 NOV 23 ... USA. Keywords: Country:Israel, Adenosine, Antiinflammatory, Arthritis, Biopharmaceuticals, Can-Fite BioPharma, Drugs, Knee Osteoarthritis, Pharmaceutical Business, Pharmaceutical ...

Subject: Arthritis

View Free
Daily News
Article

Sucampo Pharmaceuticals Invites Investors to Listen to Webcast of Presentation at Credit Suisse Conference

2009 NOV 23 ... , Health, Biotechnology, Pharmaceutical, Research, Science, Asia, Japan, Software, Biopharmaceuticals, Drugs, Pharmaceutical Business, Pharmaceutical Company, Pharmaceuticals, Sucampo ...

Subject: Sucampo Pharmaceuticals, Inc.

Price: $3.00

Symbion Systems Announces Integration of its Process Analytical Technology solutions with CAMOs Unscrambler Technology

2009 NOV 23 ... Direct: (714)913-4718 jlyons@goaxiom.com Keywords: Biopharmaceuticals, Biotechnology Business, Biotechnology Company, Diagnostics, Drugs, Pharmaceuticals, ...

Subject: Biotechnology Business

Price: $3.00

Tailwind Capital Invests in SDI Health LLC

2009 NOV 23 ... Investing, Investment, Marketing, Mergers, Politics, Private Equity, Technology, Biopharmaceuticals, Biotechnology Business, Biotechnology Company, Drugs, Pharmaceuticals, Therapies, ...

Subject: Tailwind Capital

Price: $3.00

Talecris Biotherapeutics Announces Third Quarter 2009 Results

2009 NOV 23 ... Health, Biotechnology, Pharmaceutical, Investment, Finance, Financial, Investing, Biopharmaceuticals, Biotechnology, Biotechnology Business, Biotechnology Company, Drugs, Gamunex, Talecris ...

Subject: Talecris Biotherapeutics Holdings Corp.

Price: $3.00

Tokai Pharmaceuticals Initiates ARMOR Clinical Development Program for TOK-001; First Ever Multi-Target Investigational Drug for Prostate Cancer

2009 NOV 23 ... , Health, Biotechnology, Clinical Trials, Oncology, Pharmaceutical, Consumer, Men, Biopharmaceuticals, Biotechnology, Chemotherapy, Clinical Research, Clinical Trial Research, Clinical ...

Subject: Tokai Pharmaceuticals

Price: $3.00

Viron to Present Data from Phase II Trial at American Heart Association Conference

2009 NOV 23 ... Viron Therapeutics Inc., Protein Therapies, Proteomics, Biotechnology, Genetics, Biopharmaceuticals, Drugs, Pharmaceuticals, Clinical Trial Research, Therapy, Treatment This ...

Subject: Viron Therapeutics Inc.

Price: $3.00

Voler Systems President Speaks at BIOMEDevice San Jose

2009 NOV 23 ... said Walt Maclay, president of Voler Systems. Keywords: Voler Systems, Biopharmaceuticals, Drugs, Therapies, Pharmaceuticals, Miniaturization, Therapy, Treatment. ...

Subject: Voler Systems

Price: $3.00

ZIOPHARM Reports Third Quarter Financial Results and Updated Clinical Progress

2009 NOV 23 ... Food, Common Stock, Finance, Financial, Investing, Investment, Stock Market, Biopharmaceuticals, Breast Cancer, Breast Carcinoma, Clinical Trial Research, Clinical Trials, Drugs, FDA, ...

Subject: ZIOPHARM Oncology, Inc.

Price: $3.00

Results 1 - 20 Next >


Home \| Free Newsletters \| Products \| Article Library \| About Us \| Contact \| Privacy Policy \| Search \| Visit VerticalNews.com Copyright © 2009 NewsRx